Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-23-023348
Filing Date
2023-06-23
Accepted
2023-06-23 17:15:35
Documents
3
Period of Report
2023-06-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1687554926.html 3  
1 FORM 3 wk-form3_1687554926.xml 3 3750
2 EX-24 powerofattorney_moriarty.htm EX-24 644
3 powerofattorney_moriarty001.jpg GRAPHIC 177167
  Complete submission text file 0001628280-23-023348.txt   249860
Mailing Address ALEXION PHARMACEUTICALS 352 KNOTTER DRIVE CHESHIRE CT 06410
Business Address
Moriarty John B (Reporting) CIK: 0001564621 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35921 | Film No.: 231038673

Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations